RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

  • Feature ArticlesFeature Articles

    Biosimilars: A Global Perspective

    This article focuses on global regulations emerging for biosimilar approval, the many challenges impacting the development of biosimilars and how various agencies define biologics, the evolution of guidances and data requirements for market approval, interchangeability and international nonproprietary names. The author provides an overview of the biosimilars that, over time, have been approved by regulators in various countries and regions.   Introduction   The ter...